Patents by Inventor Jeremy Kroemer

Jeremy Kroemer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cell lines having enhanced cell longevity and protein expression
    Patent number: 7842493
    Abstract: It is the object of the current invention to provide methods and compositions relating to the expression of vankyrin proteins in cell lines to increase their viability, longevity and capacity for protein production. The inventors have discovered that the expression of P-ank-1 and I2-ank-3 proteins in cell culture has increased the cells' longevity and capacity for endogenous and/or heterologous target protein production. Specifically, the present invention relates to the enhanced expression of endogenous and/or heterologous target proteins/polypeptides in recombinant cells that are also expressing P-ank-1 and/or I2-ank-3 protein compared to expression host cells that are not expressing P-ank-1 and/or I2-ank-3 protein.
    Type: Grant
    Filed: September 24, 2009
    Date of Patent: November 30, 2010
    Assignee: University of Kentucky Research Foundation
    Inventors: Bruce Allen Webb, Jeremy Kroemer
  • Vectors and methods for enhanced cell longevity and protein expression
    Patent number: 7629160
    Abstract: It is the object of the current invention to provide methods and compositions relating to the expression of vankyrin proteins in cell lines to increase their viability, longevity and capacity for protein production. The inventors have discovered that the expression of P-ank-1 and I2-ank-3 proteins in cell culture has increased the cells' longevity and capacity for endogenous and/or heterologous target protein production. Specifically, the present invention relates to the enhanced expression of endogenous and/or heterologous target proteins/polypeptides in recombinant cells that are also expressing P-ank-1 and/or I2-ank-3 protein compared to expression host cells that are not expressing P-ank-1 and/or I2-ank-3 protein.
    Type: Grant
    Filed: December 21, 2004
    Date of Patent: December 8, 2009
    Assignee: University of Kentucky Research Foundation
    Inventors: Bruce Allen Webb, Jeremy Kroemer
  • Vectors and methods for enhanced cell longevity and protein expression
    Publication number: 20060134743
    Abstract: It is the object of the current invention to provide methods and compositions relating to the expression of vankyrin proteins in cell lines to increase their viability, longevity and capacity for protein production. The inventors have discovered that the expression of P-ank-1 and I2-ank-3 proteins in cell culture has increased the cells' longevity and capacity for endogenous and/or heterologous target protein production. Specifically, the present invention relates to the enhanced expression of endogenous and/or heterologous target proteins/polypeptides in recombinant cells that are also expressing P-ank-1 and/or I2-ank-3 protein compared to expression host cells that are not expressing P-ank-1 and/or I2-ank-3 protein.
    Type: Application
    Filed: December 21, 2004
    Publication date: June 22, 2006
    Inventors: Bruce Webb, Jeremy Kroemer